MRP:
₹1590*
₹1351.5*
MRP ₹1590
15% CB
₹238.5 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Composition :
APREPITANT-205MG
Manufacturer/Marketer :
Caitlin Oncology
Consume Type :
ORAL
Return Policy :
Not Returnable
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Consult your doctor
The interaction of alcohol with Caitosa-Kit 125/80 Capsule 1's is unknown. If you have any concerns regarding this, please discuss them with your doctor.
Pregnancy
Consult your doctor
If you are pregnant or planning pregnancy, inform your doctor before taking Caitosa-Kit 125/80 Capsule 1's. Your doctor may prescribe this medicine only if clearly needed.
Breast Feeding
Consult your doctor
It is unknown whether Aprepitant is excreted in breast milk. Hence, if you are a nursing mother, inform your doctor before taking Caitosa-Kit 125/80 Capsule 1's.
Driving
Caution
Caitosa-Kit 125/80 Capsule 1's may cause dizziness or drowsiness in some people. Hence, do not drive or operate machinery if you feel dizzy or drowsy after taking Caitosa-Kit 125/80 Capsule 1's.
Liver
Caution
If you have liver disease, inform your doctor before taking Caitosa-Kit 125/80 Capsule 1's. Your doctor may monitor your liver condition.
Kidney
Consult your doctor
If you have any kidney problems, inform your doctor before taking Caitosa-Kit 125/80 Capsule 1's.
Children
Unsafe
Caitosa-Kit 125/80 Capsule 1's is not recommended for children below 12 years of age.
Product Substitutes
coupon
Drug-Drug Interactions
AprepitantEliglustat
Critical
AprepitantAstemizole
Critical
Drug-Drug Interactions
Login/Sign Up
AprepitantEliglustat
Critical
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Caitosa-Kit 125/80 Capsule combined with Eliglustat can considerably raise blood levels of Eliglustat. This raises the possibility of cardiac adverse effects such as abnormal heart rhythm, heart block, and cardiac arrest.
How to manage the interaction:
Taking Caitosa-Kit 125/80 Capsule and Eliglustat together is not recommended as it can lead to an interaction; they can be consumed if prescribed by a doctor. Consult a doctor if you have symptoms such as sudden dizziness, lightheadedness, fainting, shortness of breath, weak heart rate, weak pulse, or heart palpitations. Do not discontinue any medications without consulting a doctor.
Caitosa-Kit 125/80 Capsule combined with Eliglustat can considerably raise blood levels of Eliglustat. This raises the possibility of cardiac adverse effects such as abnormal heart rhythm, heart block, and cardiac arrest.
How to manage the interaction:
Taking Caitosa-Kit 125/80 Capsule and Eliglustat together is not recommended as it can lead to an interaction; they can be consumed if prescribed by a doctor. Consult a doctor if you have symptoms such as sudden dizziness, lightheadedness, fainting, shortness of breath, weak heart rate, weak pulse, or heart palpitations. Do not discontinue any medications without consulting a doctor.
AprepitantAstemizole
Critical
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Co-administration with Caitosa-Kit 125/80 Capsule and Astemizole may increase the blood levels of Astemizole.
How to manage the interaction:
Although taking Caitosa-Kit 125/80 Capsule and Astemizole together is not recommended as it can lead to an interaction, it is safe if your doctor has prescribed it. Contact a doctor if you have palpitations, an irregular pulse, sudden dizziness, lightheadedness, fainting, or shortness of breath. Do not stop taking any medications without visiting a doctor. Astemizole should not be combined with any other medications without a doctor's advice.
Co-administration with Caitosa-Kit 125/80 Capsule and Astemizole may increase the blood levels of Astemizole.
How to manage the interaction:
Although taking Caitosa-Kit 125/80 Capsule and Astemizole together is not recommended as it can lead to an interaction, it is safe if your doctor has prescribed it. Contact a doctor if you have palpitations, an irregular pulse, sudden dizziness, lightheadedness, fainting, or shortness of breath. Do not stop taking any medications without visiting a doctor. Astemizole should not be combined with any other medications without a doctor's advice.
AprepitantCisapride
Critical
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Co-administration with Caitosa-Kit 125/80 Capsule and Cisapride may cause irregular heart rhythm.
How to manage the interaction:
Although taking Caitosa-Kit 125/80 Capsule and Cisapride together is not recommended as it can lead to an interaction, it is safe to do so if your doctor has prescribed it. Contact a doctor if you have palpitations, an irregular pulse, sudden dizziness, lightheadedness, fainting, or shortness of breath. Do not stop taking any medications without visiting a doctor.
Co-administration with Caitosa-Kit 125/80 Capsule and Cisapride may cause irregular heart rhythm.
How to manage the interaction:
Although taking Caitosa-Kit 125/80 Capsule and Cisapride together is not recommended as it can lead to an interaction, it is safe to do so if your doctor has prescribed it. Contact a doctor if you have palpitations, an irregular pulse, sudden dizziness, lightheadedness, fainting, or shortness of breath. Do not stop taking any medications without visiting a doctor.
AprepitantPimozide
Critical
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Using pimozide together with Caitosa-Kit 125/80 Capsule may significantly increase the blood levels of pimozide. High blood levels of pimozide can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Caitosa-Kit 125/80 Capsule and Pimozide together is not recommended; as it can lead to an interaction, you can take them if your doctor advises you to. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, or a rapid heartbeat, get immediate medical help. Do not discontinue any medications without consulting a doctor.
Using pimozide together with Caitosa-Kit 125/80 Capsule may significantly increase the blood levels of pimozide. High blood levels of pimozide can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking Caitosa-Kit 125/80 Capsule and Pimozide together is not recommended; as it can lead to an interaction, you can take them if your doctor advises you to. If you experience sudden dizziness, lightheadedness, fainting, shortness of breath, or a rapid heartbeat, get immediate medical help. Do not discontinue any medications without consulting a doctor.
AprepitantTerfenadine
Critical
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Co-administration with Caitosa-Kit 125/80 Capsule and Terfenadine may increase the blood levels of Terfenadine and leads to irregular heartbeat.
How to manage the interaction:
Taking Caitosa-Kit 125/80 Capsule and Terfenadine together is not recommended as it can lead to an interaction. It is safe to do so if your doctor has prescribed it. Contact a doctor if you have palpitations, an irregular pulse, sudden dizziness, lightheadedness, fainting, or shortness of breath. Do not stop taking any medications without visiting a doctor.
Co-administration with Caitosa-Kit 125/80 Capsule and Terfenadine may increase the blood levels of Terfenadine and leads to irregular heartbeat.
How to manage the interaction:
Taking Caitosa-Kit 125/80 Capsule and Terfenadine together is not recommended as it can lead to an interaction. It is safe to do so if your doctor has prescribed it. Contact a doctor if you have palpitations, an irregular pulse, sudden dizziness, lightheadedness, fainting, or shortness of breath. Do not stop taking any medications without visiting a doctor.
AprepitantLomitapide
Critical
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Lomitapide blood levels can be significantly increased by combining it with Caitosa-Kit 125/80 Capsule.
How to manage the interaction:
Although using Lomitapide and Caitosa-Kit 125/80 Capsule together may cause an interaction, they can be taken if advised by a doctor. Consult a doctor if you have any of the following symptoms: diarrhea, nausea, vomiting, stomach pain or discomfort, indigestion, gas, constipation, liver problems causing fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of hunger, weakness, nausea, vomiting, dark colored urine, light-colored stools, and yellowing of the skin or eyes. Do not discontinue any medications without consulting a doctor.
Lomitapide blood levels can be significantly increased by combining it with Caitosa-Kit 125/80 Capsule.
How to manage the interaction:
Although using Lomitapide and Caitosa-Kit 125/80 Capsule together may cause an interaction, they can be taken if advised by a doctor. Consult a doctor if you have any of the following symptoms: diarrhea, nausea, vomiting, stomach pain or discomfort, indigestion, gas, constipation, liver problems causing fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of hunger, weakness, nausea, vomiting, dark colored urine, light-colored stools, and yellowing of the skin or eyes. Do not discontinue any medications without consulting a doctor.
AprepitantFlibanserin
Critical
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Using flibanserin together with Caitosa-Kit 125/80 Capsule can significantly increase the blood levels of flibanserin.
How to manage the interaction:
Taking Flibanserin and Caitosa-Kit 125/80 Capsule together is not recommended as it can lead to an interaction; they can be taken if prescribed by a doctor. Consult a doctor if you develop any symptoms, such as extreme sleepiness or low blood pressure, that cause dizziness, lightheadedness, or fainting. To reduce the chance of these side effects, use Flibanserin at bedtime. Do not discontinue any medications without consulting a doctor.
Using flibanserin together with Caitosa-Kit 125/80 Capsule can significantly increase the blood levels of flibanserin.
How to manage the interaction:
Taking Flibanserin and Caitosa-Kit 125/80 Capsule together is not recommended as it can lead to an interaction; they can be taken if prescribed by a doctor. Consult a doctor if you develop any symptoms, such as extreme sleepiness or low blood pressure, that cause dizziness, lightheadedness, or fainting. To reduce the chance of these side effects, use Flibanserin at bedtime. Do not discontinue any medications without consulting a doctor.
AprepitantAlfentanil
Severe
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Coadministration of apepitant and alfentanil's can increase the blood levels of alfentanil.
How to manage the interaction:
Despite the fact that Caitosa-Kit 125/80 Capsule and Alfentanil interact, it can be taken if prescribed by a doctor. Consult a doctor if you suffer symptoms such as severe drowziness, breathing difficulties, low blood pressure, or irregular heart beat. Do not discontinue any medications without consulting a doctor.
Coadministration of apepitant and alfentanil's can increase the blood levels of alfentanil.
How to manage the interaction:
Despite the fact that Caitosa-Kit 125/80 Capsule and Alfentanil interact, it can be taken if prescribed by a doctor. Consult a doctor if you suffer symptoms such as severe drowziness, breathing difficulties, low blood pressure, or irregular heart beat. Do not discontinue any medications without consulting a doctor.
AprepitantAcalabrutinib
Severe
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Coadministration of Caitosa-Kit 125/80 Capsule can significantly increase the blood levels of Acalabrutinib.
How to manage the interaction:
Although there is an interaction between Caitosa-Kit 125/80 Capsule and acalabrutinib, it can be taken if prescribed by a doctor. A doctor should be consulted if you experience any of the following symptoms: paleness, tiredness, dizziness, fainting, unusual bruising or bleeding, fever, chills, diarrhea, sore throat, muscular aches, shortness of breath, blood in the phlegm, red or irritated skin, body sores, and discomfort when urinating. Without consulting a doctor, never stop taking medicines.
Coadministration of Caitosa-Kit 125/80 Capsule can significantly increase the blood levels of Acalabrutinib.
How to manage the interaction:
Although there is an interaction between Caitosa-Kit 125/80 Capsule and acalabrutinib, it can be taken if prescribed by a doctor. A doctor should be consulted if you experience any of the following symptoms: paleness, tiredness, dizziness, fainting, unusual bruising or bleeding, fever, chills, diarrhea, sore throat, muscular aches, shortness of breath, blood in the phlegm, red or irritated skin, body sores, and discomfort when urinating. Without consulting a doctor, never stop taking medicines.
AprepitantEplerenone
Severe
How does the drug interact with Caitosa-Kit 125/80 Capsule:
Eplerenone levels in the blood may be significantly elevated by Caitosa-Kit 125/80 Capsule.This could make adverse effects more severe.
How to manage the interaction:
Although coadministration of Caitosa-Kit 125/80 Capsule and Eplerenone can lead to an interaction, they can be taken if prescribed by a doctor Consult a doctor if you have any kidney-related symptoms (swollen ankles, tiredness, shortness of breath, difficulty in sleeping, itchy skin), nausea, vomiting, weakness, confusion, tingling in the hands and feet, heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Without consulting a doctor, never stop taking medicines.
Eplerenone levels in the blood may be significantly elevated by Caitosa-Kit 125/80 Capsule.This could make adverse effects more severe.
How to manage the interaction:
Although coadministration of Caitosa-Kit 125/80 Capsule and Eplerenone can lead to an interaction, they can be taken if prescribed by a doctor Consult a doctor if you have any kidney-related symptoms (swollen ankles, tiredness, shortness of breath, difficulty in sleeping, itchy skin), nausea, vomiting, weakness, confusion, tingling in the hands and feet, heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Without consulting a doctor, never stop taking medicines.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
APREPITANT-205MGAlcoholic liver disease
Moderate
Drug-Diseases Interactions
Login/Sign Up
APREPITANT-205MGAlcoholic liver disease
Moderate
How does the disease interact with Caitosa-Kit 125/80 Capsule:
The liver is primarily responsible for Caitosa-Kit 125/80 Capsule metabolism. Caitosa-Kit 125/80 Capsule was well tolerated in investigations of patients with mild to moderate hepatic impairment (Child-Pugh score 5 to 9), and no clinically significant changes in its pharmacokinetics were seen. As a result, there is no need to change the dosage of Caitosa-Kit 125/80 Capsule in this patient population. Caitosa-Kit 125/80 Capsule should be used with caution in patients with severe hepatic impairment (Child-Pugh score > 9), as there is no clinical or pharmacokinetic data in this population.
How to manage the interaction:
Caitosa-Kit 125/80 Capsule is metabolized by the liver, hence it is usually not recommended in patients with mild to moderate liver disease as it can increase the Caitosa-Kit 125/80 Capsule level in the body. Increased levels can increase the risk and severity of Caitosa-Kit 125/80 Capsule side effects. However, you can take it when advised by your doctor. If you experience headache, fatigue, low appetite, constipation, diarrhea, nausea, and hiccups contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
The liver is primarily responsible for Caitosa-Kit 125/80 Capsule metabolism. Caitosa-Kit 125/80 Capsule was well tolerated in investigations of patients with mild to moderate hepatic impairment (Child-Pugh score 5 to 9), and no clinically significant changes in its pharmacokinetics were seen. As a result, there is no need to change the dosage of Caitosa-Kit 125/80 Capsule in this patient population. Caitosa-Kit 125/80 Capsule should be used with caution in patients with severe hepatic impairment (Child-Pugh score > 9), as there is no clinical or pharmacokinetic data in this population.
How to manage the interaction:
Caitosa-Kit 125/80 Capsule is metabolized by the liver, hence it is usually not recommended in patients with mild to moderate liver disease as it can increase the Caitosa-Kit 125/80 Capsule level in the body. Increased levels can increase the risk and severity of Caitosa-Kit 125/80 Capsule side effects. However, you can take it when advised by your doctor. If you experience headache, fatigue, low appetite, constipation, diarrhea, nausea, and hiccups contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Caitosa-Kit 125/80 Capsule 1's Substitute
Apriswift 125/80Mg Capsule Kit 1'S
by AYUR
₹1496.70per tabletApregen 125 mg/80 mg Kit 1's
by Others
₹1289.00per tabletAprecin-V Capsule Kit 3's
by Others
₹516.67per tablet
